Shanghai Titan Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	730.25	881.47	985.98	1,051	1,390	675.95
Trading Asset Securities	43.95	34.17	40.26	-	-	11
Cash & Short-Term Investments	774.2	915.65	1,026	1,051	1,390	686.95
Cash Growth	-10.19%	-10.78%	-2.31%	-24.43%	102.36%	-21.40%
Accounts Receivable	802.21	809.08	834.19	871.02	705.77	594.01
Other Receivables	54.81	14.08	15.08	16.28	18.67	21.3
Receivables	857.01	823.16	849.27	887.29	724.44	615.31
Inventory	1,058	1,056	1,064	989.88	850.5	590.65
Other Current Assets	233.98	180.34	199.27	176.65	173.78	196.54
Total Current Assets	2,924	2,975	3,139	3,104	3,139	2,089
Property, Plant & Equipment	1,291	1,278	1,015	753.75	384.25	212.27
Long-Term Investments	115.13	115.02	106.45	103.24	78.66	47.58
Goodwill	123.07	123.07	152.62	100.74	100.74	100.74
Other Intangible Assets	193.2	198.54	209.93	191.57	192.5	87
Long-Term Deferred Tax Assets	38.78	39.69	27.19	25.22	15.37	10.69
Long-Term Deferred Charges	97.93	103.05	113.28	54.25	23.45	31.77
Other Long-Term Assets	71.9	34.62	85.04	55.19	37.8	13.85
Total Assets	4,855	4,867	4,849	4,388	3,972	2,593
Accounts Payable	166.47	167.96	198.3	165.05	153.52	155.53
Accrued Expenses	25.34	85.37	78.69	72.36	64.09	45.19
Short-Term Debt	924.1	1,016	984.57	728.38	509.11	341.18
Current Portion of Long-Term Debt	191.99	148.72	83.99	55.82	30.01	0.84
Current Portion of Leases	-	10.6	13.16	14.85	10.65	6.39
Current Income Taxes Payable	56.66	1.81	1.08	2.32	11.05	21.5
Current Unearned Revenue	54.47	45.6	55.64	72.65	73.5	76.52
Other Current Liabilities	190.77	53.3	40.92	32.56	36.71	201.31
Total Current Liabilities	1,610	1,529	1,456	1,144	888.65	848.45
Long-Term Debt	371.18	416.38	434.38	322.38	270.25	108.28
Long-Term Leases	39.67	46.11	25.52	34.51	23.87	8.11
Long-Term Unearned Revenue	17.9	20.82	17.24	22.01	16.44	2.39
Long-Term Deferred Tax Liabilities	19.41	20.45	14.49	15.25	5.73	4.69
Other Long-Term Liabilities	8	8	30	-	-	5.39
Total Liabilities	2,066	2,041	1,978	1,538	1,205	977.3
Common Stock	164.44	164.44	164.44	117.97	84.07	76.25
Additional Paid-In Capital	2,093	2,091	2,083	2,137	2,155	1,136
Retained Earnings	453.28	485.67	528.1	526.95	473.81	363.73
Comprehensive Income & Other	10.03	12.21	10.55	9.1	6.51	-0.18
Total Common Equity	2,721	2,753	2,786	2,791	2,720	1,576
Minority Interest	68.45	72.51	84.57	59.57	46.97	40.06
Shareholders' Equity	2,789	2,826	2,871	2,850	2,767	1,616
Total Liabilities & Equity	4,855	4,867	4,849	4,388	3,972	2,593
Total Debt	1,527	1,638	1,542	1,156	843.89	464.79
Net Cash (Debt)	-752.75	-722.08	-515.37	-105.38	546.23	222.16
Net Cash Growth	-	-	-	-	145.87%	-67.67%
Net Cash Per Share	-4.69	-4.44	-3.20	-0.64	3.53	1.49
Filing Date Shares Outstanding	164.44	164.44	164.44	165.16	164.78	149.45
Total Common Shares Outstanding	164.44	164.44	164.44	165.16	164.78	149.45
Working Capital	1,314	1,445	1,683	1,960	2,250	1,241
Book Value Per Share	16.55	16.74	16.94	16.90	16.51	10.55
Tangible Book Value	2,404	2,432	2,424	2,498	2,426	1,388
Tangible Book Value Per Share	14.62	14.79	14.74	15.13	14.73	9.29
Buildings	-	1,014	260.37	259.91	56.02	54.55
Machinery	-	423.9	308.26	218.58	114.22	90.82
Construction In Progress	-	0.12	561.88	330.12	254.89	113.47